Online citations, reference lists, and bibliographies.
← Back to Search

Iron Oxide Nanoparticles: Innovative Tool In Cancer Diagnosis And Therapy

P. Martínková, Martin Brtnicky, Jindřich Kýnický, M. Pohanka
Published 2018 · Medicine
Referenced 1 time by Citationsy Users

Cite This
Download PDF
Analyze on Scholarcy
Share
Although cancer is one of the most dangerous and the second most lethal disease in the world, current therapy including surgery, chemotherapy, radiotherapy, etc., is highly insufficient not in the view of therapy success rate or the amount of side effects. Accordingly, procedures with better outcomes are highly desirable. Iron oxide nanoparticles (IONPs) present an innovative tool-ideal for innovation and implementation into practice. This review is focused on summarizing some well-known facts about pharmacokinetics, toxicity, and the types of IONPs, and furthermore, provides a survey of their use in cancer diagnosis and therapy.
This paper references
10.1016/j.jconrel.2015.09.029
Hybrid nanoparticles for combination therapy of cancer.
Chunbai He (2015)
10.1016/j.jcis.2009.04.046
Cell toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2009)
10.1016/j.msec.2015.11.067
Polymeric nanoparticles for targeted drug delivery system for cancer therapy.
F. Masood (2016)
10.2217/nnm.13.118
Current trends in the use of liposomes for tumor targeting.
Pranali P. Deshpande (2013)
10.1088/0031-9155/45/5/201
Hyperthermia treatment planning.
J. Lagendijk (1986)
10.1007/s40820-015-0065-1
Bovine Serum Albumin-Conjugated Ferrimagnetic Iron Oxide Nanoparticles to Enhance the Biocompatibility and Magnetic Hyperthermia Performance
Viveka Kalidasan (2016)
10.1016/j.rpor.2013.09.011
Magnetic nanoparticle-based hyperthermia for cancer treatment.
M. Bañobre-López (2013)
10.1016/j.tips.2009.08.004
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Y. Malam (2009)
10.1016/j.canlet.2016.12.026
Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy.
Xiaoyang Hou (2017)
10.2214/AJR.04.1287
Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
M. Harisinghani (2006)
10.1002/jmri.21359
Comparison of lipid‐rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: Initial results
V. Cappendijk (2008)
10.7150/thno.11544
Magnetic Nanoparticles in Cancer Theranostics
O. Gobbo (2015)
10.1007/s11427-011-4215-5
The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell
Jingli Gu (2011)
10.1166/JNN.2010.2461
Anti-cancer drug loaded iron-gold core-shell nanoparticles (Fe@Au) for magnetic drug targeting.
S. Kayal (2010)
10.1088/0022-3727/36/13/202
The preparation of magnetic nanoparticles for applications in biomedicine
P. Tartaj (2003)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1016/j.biomaterials.2014.10.064
Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation.
S. Shen (2015)
10.1016/J.MATTOD.2015.08.022
Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances.
R. Revia (2016)
10.1016/j.biopha.2014.04.003
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Gozde Unsoy (2014)
10.2147/IJN.S1608
Magnetic nanoparticles for gene and drug delivery
S. McBain (2008)
10.1021/ar200084x
Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
C. Tassa (2011)
10.1016/j.colsurfb.2009.05.031
Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
Yuqing Ge (2009)
10.1002/AIC.12373
Acid-Sensitive Magnetic Nanoparticles as Potential Drug Depots.
S. C. Wuang (2011)
10.2174/187152007780618135
MRI contrast agents: current status and future perspectives.
G. Strijkers (2007)
10.1038/jcbfm.2009.192
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
J. Weinstein (2010)
10.3109/21691401.2014.1001493
Development of gemcitabine-adsorbed magnetic gelatin nanoparticles for targeted drug delivery in lung cancer
Şenay Hamarat Şanlıer (2016)
10.1016/j.talanta.2013.12.028
Prussian blue nanoparticles as peroxidase mimetics for sensitive colorimetric detection of hydrogen peroxide and glucose.
W. Zhang (2014)
10.1088/0022-3727/36/13/203
TOPICAL REVIEW: Functionalisation of magnetic nanoparticles for applications in biomedicine
C. Berry (2003)
10.1016/J.JMMM.2016.11.025
The magnetic introduction of magnetite nanoparticles into live cells for radiosensibility enhancement
A. Yurenya (2017)
10.1016/J.NANTOD.2010.05.003
Functionalisation of nanoparticles for biomedical applications
N. T. Thanh (2010)
10.3109/21691401.2015.1014093
Magnetic nanoparticles: Applications in gene delivery and gene therapy
S. Majidi (2016)
10.1039/c5cs00541h
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.
H. Arami (2015)
10.18632/ONCOTARGET.490
Targeting Cancer Gene Therapy with Magnetic Nanoparticles
C. Li (2012)
10.1016/J.JMMM.2016.12.119
MgFe2O4/ZrO2 composite nanoparticles for hyperthermia applications
A. Rashid (2017)
10.1016/J.JMMM.2017.03.055
Stabilization of temperature during magnetic hyperthermia by Ce substituted magnetite nanoparticles
S. K. Shaw (2017)
10.3892/etm.2012.656
Genotoxicity and carcinogenicity of cobalt-, nickel- and copper-based nanoparticles
Ruth Magaye (2012)
10.3390/ma6062393
Terahertz Wave Propagation in a Nanotube Conveying Fluid Taking into Account Surface Effect
Y. Zhang (2013)
10.1016/J.MATTOD.2013.07.004
The fascinating world of nanoparticle research
F. J. Heiligtag (2013)
10.1016/j.jconrel.2016.07.005
Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy.
J. Wang (2016)
10.1016/j.biomaterials.2012.08.036
Riboflavin carrier protein-targeted fluorescent USPIO for the assessment of vascular metabolism in tumors.
Jabadurai Jayapaul (2012)
10.3390/ijms151018776
Biocompatible PEGylated Fe3O4 Nanoparticles as Photothermal Agents for Near-Infrared Light Modulated Cancer Therapy
Gang Yuan (2014)
10.3390/ijms140714550
Chemical and Colloidal Stability of Carboxylated Core-Shell Magnetite Nanoparticles Designed for Biomedical Applications
M. Szekeres (2013)
10.1155/2011/685081
Synthesis, properties, and applications of low-dimensional carbon-related nanomaterials
A. Mostofizadeh (2011)
10.1097/01.rli.0000197669.80475.dd
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
P. Bourrinet (2006)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
10.1097/RLI.0000000000000230
Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults
Anne M Muehe (2016)
10.2147/IJN.S30320
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin (2012)
10.2214/AJR.15.14534
Vascular Imaging With Ferumoxytol as a Contrast Agent.
M. Hope (2015)
10.2147/IJN.S77667
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
L. Zhang (2015)
10.3109/17435390.2014.980450
Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration
A. Al Faraj (2015)
10.12693/APHYSPOLA.131.1159
Elimination of Magnetic Nanoparticles with Various Surface Modifications from the Bloodstream in vivo
N. Tomašovičová (2017)
10.1016/J.JALLCOM.2017.01.297
Enhanced magnetic hyperthermia of CoFe2O4 and MnFe2O4 nanoparticles
M. M. Cruz (2017)
10.2147/IJN.S10458
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells
X. Wu (2010)
10.1016/j.drudis.2015.06.008
Therapeutic approaches of magnetic nanoparticles for the central nervous system.
F. Dilnawaz (2015)
10.7785/tcrt.2012.500333
Drug Embedded PVP Coated Magnetic Nanoparticles for Targeted Killing of Breast Cancer Cells
P. Rose (2013)
10.1371/journal.pone.0158084
Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications
M. Nadeem (2016)
10.1002/ajim.20855
Pulmonary and systemic toxicity following exposure to nickel nanoparticles.
J. I. Phillips (2010)
10.1088/0957-4484/20/30/305101
Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
S. Purushotham (2009)
10.2217/nnm-2017-0014
Magnetic nanoparticles in cancer therapy: how can thermal approaches help?
Jelena Kolosnjaj-Tabi (2017)
10.1021/la502952f
Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin.
Xubo Zhao (2014)
10.1088/0957-4484/26/20/205101
Safety assessment of chronic oral exposure to iron oxide nanoparticles.
S. Chamorro (2015)
10.2147/IJN.S23638
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study
Eva K Schlachter (2011)
10.1016/j.cbi.2014.11.016
Toxicity of cobalt oxide nanoparticles to normal cells; an in vitro and in vivo study.
S. Chattopadhyay (2015)
10.1016/S0304-8853(99)00088-8
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
A. Jordan (1999)
10.2147/IJN.S56932
Polymeric nanoparticles for targeted treatment in oncology: current insights
R. Prabhu (2015)
10.1002/jmri.24691
Emerging applications for ferumoxytol as a contrast agent in MRI
M. Bashir (2015)
10.1088/1468-6996/16/2/023501
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
Wei Wu (2015)
pH sensitive core-shell magnetic nanoparticles for targeted drug delivery in cancer therapy.
I. Lungu (2016)
10.1038/s41598-017-00836-y
Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications
M. Patitsa (2017)
10.1016/J.BIOMATERIALS.2007.08.050
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.
B. Chertok (2008)
10.1016/j.biomaterials.2016.07.030
Bacterial magnetic nanoparticles for photothermal therapy of cancer under the guidance of MRI.
Chuanfang Chen (2016)
10.1021/JP0633906
Synthesis of hematite (alpha-Fe2O3) nanorods: diameter-size and shape effects on their applications in magnetism, lithium ion battery, and gas sensors.
Changzheng Wu (2006)
10.1016/j.mehy.2009.01.031
A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia.
G. Ciofani (2009)
10.1063/1.4867756
Intracellular performance of tailored nanoparticle tracers in magnetic particle imaging.
H. Arami (2014)
10.1208/s12249-014-0131-x
Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release
R. Dani (2014)
10.1016/j.actbio.2016.04.026
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Indranil Banerjee (2016)
10.2147/IJN.S76501
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
J. Estelrich (2015)
10.2147/IJN.S68719
Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia
Shih-Hsiang Liao (2015)
10.1093/TOXSCI/KFJ027
Toxicity and tissue distribution of magnetic nanoparticles in mice.
J. Kim (2006)
10.1038/mt.2010.236
Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro.
Julia V. Georgieva (2011)
10.1002/ANIE.200602866
Magnetic nanoparticles: synthesis, protection, functionalization, and application.
A. Lu (2007)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1263/JBB.100.1
Medical application of functionalized magnetic nanoparticles.
A. Ito (2005)
10.1155/2011/408675
Emerging technologies of polymeric nanoparticles in cancer drug delivery
E. Brewer (2011)
10.1016/j.biomaterials.2010.11.040
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Adam J. Cole (2011)
10.1016/j.jconrel.2016.09.009
Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy.
Ingrid Brezániová (2016)
10.1016/J.MATDES.2017.03.036
Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application
Z. Hedayatnasab (2017)
10.1186/1556-276X-7-144
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
A. Akbarzadeh (2012)
10.1016/S1369-7021(05)00893-X
Magnetic nanoparticle probes
L. LaConte (2005)
10.1088/0957-4484/19/16/165101
Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent.
Ha-young Lee (2008)
10.1016/j.bios.2008.06.032
Iron oxide nanoparticles-chitosan composite based glucose biosensor.
Ajeet Kaushik (2008)
10.4103/2230-973X.160844
Mesoporous silica nanoparticles in target drug delivery system: A review
C. Bharti (2015)
10.1039/c4nr03482a
Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
Aziliz Hervault (2014)
10.1016/j.carbpol.2016.11.091
Magnetic nanoparticles coated with cyclodextrins and citrate for irinotecan delivery.
A. P. F. Monteiro (2017)
10.1088/0957-4484/22/34/345101
Magnetic nanoparticle biodistribution following intratumoral administration.
A. J. Giustini (2011)
10.1186/s12951-017-0257-6
Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry
A. G. Próspero (2017)
10.1016/J.JMMM.2016.08.023
Simultaneous hyperthermia and doxorubicin delivery from polymer-coated magnetite nanoparticles
G. Iglesias (2017)
10.1016/j.msec.2017.03.309
Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery.
Mengmeng Song (2017)
10.1007/s11814-014-0156-6
Functionalization of magnetic nanoparticles for biomedical applications
D. Nguyen (2014)
10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
10.1016/j.ijpharm.2017.01.004
Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells.
P. L. Goto (2017)
10.1016/j.phrs.2010.01.014
Magnetic nanoparticles and targeted drug delivering.
J. Chomoucka (2010)
10.1016/J.JMMM.2016.11.024
Improvement of drug delivery by hyperthermia treatment using magnetic cubic cobalt ferrite nanoparticles
C. Dey (2017)
10.3109/21691401.2014.982802
Current methods for synthesis of magnetic nanoparticles
S. Majidi (2016)
10.1016/j.clim.2016.07.013
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).
F. Valdora (2016)
10.2174/138920021131400109
Pharmacokinetics and applications of magnetic nanoparticles.
Runyi Mao (2013)
10.1161/01.STR.0000236063.47539.99
Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI
T. Tang (2006)
10.1002/jbm.a.34871
Graphene oxide nanoparticles for enhanced photothermal cancer cell therapy under the irradiation of a femtosecond laser beam.
J. Li (2014)
10.1208/s12249-014-0113-z
Polymeric Micelles: Nanocarriers for Cancer-Targeted Drug Delivery
Y. Zhang (2014)
10.1007/978-1-59745-210-6_10
pH-responsive nanoparticles for cancer drug delivery.
Youqing Shen (2008)
10.3390/ijms151121253
Nickel Nanoparticles Exposure and Reproductive Toxicity in Healthy Adult Rats
L. Kong (2014)
10.1038/ki.2008.496
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
E. Neuwelt (2009)
10.1016/J.CRHY.2011.06.001
Nanomedicine, Nanotechnology in medicine
P. Boisseau (2011)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.3109/10717544.2013.834412
Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells
C. Y. Acevedo-Morantes (2013)
10.1002/jbm.a.31775
Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia.
D. Kim (2009)
10.1016/J.NANTOD.2015.10.001
Biotransformations of magnetic nanoparticles in the body
Jelena Kolosnjaj-Tabi (2016)
10.1007/s11095-012-0679-7
Magnetic Nanoparticles for Cancer Diagnosis and Therapy
M. V. Yigit (2012)
10.1002/(SICI)1522-2586(199902)9:2<291::AID-JMRI21>3.0.CO;2-#
Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran‐10: Phase II clinical trial data
R. Sharma (1999)
10.2217/nnm.15.148
Bioapplications of boron nitride nanotubes.
G. Genchi (2015)
10.1016/J.JCRPR.2016.12.001
Research on cancer: Why we need to switch the focus from mechanistic research to epidemiology and randomized trials
N. Temple (2017)
10.1186/1475-2867-13-89
Acidic extracellular microenvironment and cancer
Y. Kato (2013)
10.1016/J.IJPHARM.2016.10.007
Changes in apoptosis-related gene expression and cytokine release in breast cancer cells treated with CpG-loaded magnetic PAMAM nanoparticles
N. T. Pourianazar (2016)
10.1016/j.bbcan.2010.02.004
Carbon nanotubes in cancer diagnosis and therapy.
Shun-rong Ji (2010)
10.1007/s11060-006-9195-0
Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme
K. Maier-Hauff (2006)
10.1016/S0032-3861(99)00685-0
Novel pH-sensitive chitosan hydrogels: swelling behavior and states of water
X. Qu (2000)
10.1016/j.nucmedbio.2016.05.002
Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab.
B. Azadbakht (2017)
10.1016/J.JIEC.2016.12.020
Preparation of gold core-mesoporous iron-oxide shell nanoparticles and their application as dual MR/CT contrast agent in human gastric cancer cells
Aastha Kukreja (2017)
10.1002/adma.201200653
Hybrid nanoparticles for detection and treatment of cancer.
M. Sailor (2012)
10.1088/1361-6560/aa5601
Combining magnetic particle imaging and magnetic fluid hyperthermia in a theranostic platform.
D. Hensley (2017)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1007/s13204-013-0216-y
Magnetic nanoparticle drug delivery systems for targeting tumor
V. Mody (2013)
10.2147/IJN.S13662
Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice
J. Wang (2010)
10.1002/btm2.10003
Nanoparticles in the clinic
Aaron C. Anselmo (2016)
10.2478/v10019-011-0001-z
Magnetic nanoparticles as targeted delivery systems in oncology
Sara Prijic (2011)
10.1016/j.toxrep.2014.11.002
In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles
Sudeep Shukla (2015)
10.1021/nn305719y
Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring.
Lénaic Lartigue (2013)



This paper is referenced by
10.1007/978-3-030-30930-5_9
Role of Supermagnetic Nanoparticles in Alzheimer Disease
Shanmugam Rajeshkumar (2019)
10.1016/j.ecoenv.2018.09.077
Current approaches for safer design of engineered nanomaterials.
Ruth Hwang (2018)
10.1016/j.ijpharm.2019.118743
Potential anticancer activity of protocatechuic acid loaded in montmorillonite/Fe3O4 nanocomposites stabilized by seaweed Kappaphycus alvarezii.
Yen Pin Yew (2019)
10.15671/hjbc.519916
Amoxicillin Loaded Magnetic Nanoparticles Developed For Treatment of Osteomyelitis
Güliz Ak (2020)
10.1016/j.jddst.2019.101348
Delivery of erlotinib for enhanced cancer treatment: An update review on particulate systems
D. H. Truong (2020)
10.1080/00032719.2018.1542434
Nanomaterials as Pseudocatalysts in the Construction of Electrochemical Nonenzymatic Sensors for Healthcare: A Review
P. Martínková (2019)
10.1021/acsomega.9b02567
Development of a Theoretical Model That Predicts Optothermal Energy Conversion of Gold Metallic Nanoparticles
Nahid Rafiei (2020)
10.3390/biom10050735
Nanotechnology-Based Strategies to Develop New Anticancer Therapies
M. Magro (2020)
10.2217/nnm-2018-0372
Magnetic calcium phosphates nanocomposites for the intracellular hyperthermia of cancers of bone and brain.
Alessio Adamiano (2019)
10.3390/ijms20010095
Iron Metabolism in Cancer
Yafang Wang (2018)
10.3390/ijms21144851
Green Synthesized Montmorillonite/Carrageenan/Fe3O4 Nanocomposites for pH-Responsive Release of Protocatechuic Acid and Its Anticancer Activity
Yen Pin Yew (2020)
10.1186/s42833-019-0002-6
Multifunctional magnetic iron oxide nanoparticles: diverse synthetic approaches, surface modifications, cytotoxicity towards biomedical and industrial applications
Subramanian Natarajan (2019)
10.3390/biomedicines8090347
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
Lavinia Salama (2020)
10.3390/molecules25071605
Encapsulation for Cancer Therapy
Xavier Montané (2020)
10.1088/1361-6528/aafbff
Aggregation effects on the magnetic properties of iron oxide colloids.
L. Gutiérrez (2019)
10.3390/nano10091646
Multifunctional Fe3O4-Au Nanoparticles for the MRI Diagnosis and Potential Treatment of Liver Cancer
Elena Kozenkova (2020)
10.1098/rsif.2018.0236
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases
A. Marrella (2018)
10.1016/j.jcis.2020.04.026
A novel intratumoral pH/redox-dual-responsive nanoplatform for cancer MR imaging and therapy.
L. Wan (2020)
10.1039/c9nr09683c
Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine.
M. Ledda (2020)
Semantic Scholar Logo Some data provided by SemanticScholar